Alexion, AstraZeneca Rare Disease in Deal with Pfizer

Covington & Burling advised Alexion on the transaction while Arnold & Porter represented Pfizer.AstraZeneca Rare Disease announced its entry into a definitive purchase and license agreement for…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here